Fibrinogen, other putative markers of inflammation, and weight gain in middle-aged adults - The ARIC study

Obesity Research

Volumn 8, Issue 4, 2000, Pages 279-286

  Duncan, Bruce B ^a,b,d   Schmidt, Maria Ines ^a,b   Chambless, Lloyd E ^b   Folsom, Aaron R ^c   Carpenter, Myra ^b   Heiss, Gerardo ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b IL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

Author keywords

Albumins; Factor VIII; Leukocytes; Von Willebrand factor

Indexed keywords

BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; FIBRINOGEN; VON WILLEBRAND FACTOR;

ARTERIOSCLEROSIS; ARTICLE; BLOOD; COHORT ANALYSIS; FEMALE; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL; WEIGHT GAIN;

ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; COHORT STUDIES; FACTOR VIII; FEMALE; FIBRINOGEN; HUMANS; INFLAMMATION; LEUKOCYTE COUNT; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; VON WILLEBRAND FACTOR; WEIGHT GAIN;

EID: 0034222856     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2000.33     Document Type: Article

References (55)

1. World Health Organization. World Health Report, 1997: Conquering Suffering, Enriching Humanity. Geneva: World Health Organization; 1997.
2. Wickelgren I. Obesity: how big a problem? Science. 1998; 280:1364-7.
3. Taubes G. As obesity rates rise, experts struggle to explain why. Science. 1998;280:1367-8.
4. Hill JO, Peters JC. Environmental contributions to the obesity epidemic. Science. 1998;280:1371-4.
5. Woods SC, Seeley RJ, Porte D Jr. Signals that regulate food intake and energy homeostasis. Science. 1998;280:1378-83.
6. Ravussin E, Swinburn BA. Energy expenditure and obesity. Diabetes Rev. 1996;4:403-22.
7. Flatt JP. Substrate utilization and obesity. Diabetes Rev. 1998;4:433-49.
8. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340:115-26.
9. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997; 336:973-9.
10. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation. 1997;96:1102-8.
11. Lindberg G, Gullberg B, Eklund GA. Serum sialic acid concentration predicts both coronary heart disease and stroke mortality: multivariate analysis including 54,385 men and women during 20.5 years follow-up. Int J Epidemiol. 1992; 21:253-7.
12. Lindberg G, Lundblad A, Gullberg B, Nilsson-Ehle P, Hanson BS. Serum total sialic acid and sialoprotein concen-tration in relation to coronary heart disease risk markers. Atherosclerosis. 1993;103:123-9.
13. Friedman GD, Klatsky AL, Siegelaub AB. The leukocyte count as a predictor of myocardial infarction. N Engl J Med. 1974;290:1275-8.
14. Yarnell JWG, Baker IA, Sweetnam PA. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991;83:836-44.
15. Kostis JB, Turkevich D, Sharp J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am J Cardiol. 1984;53:997-9.
16. Meade TW, Cooper JA, Stirling Y, Howarth DJ, Ruddock V, Miller GJ. Factor VIII, ABO blood group and the incidence of ischaemic heart disease. Br J Haematol. 1994;88: 601-7.
17. Hwang SJ, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation. 1997;96:4219-25.
18. Berliner JA, Navab M, Fogelman AM, et al. Atherosclerosis: basic mechanisms. Circulation. 1995;91:2488-96.
19. Libby P, Geng YJ, Sukhova GK, Simon DI, Lee RT. Molecular determinants of atherosclerotic plaque vulnerability. Ann N Y Acad Sci. 1997;811:134-42.
20. Vallance P, Jollier J, Bhagat K. Infection, inflammation, and infarction: does acute endothelial dysfunction provide a link? Lancet. 1997;349:1391-2.
21. DeFronzo RA, Ferranini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and other atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-94.
22. Schmidt MI, Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Atherosclerosis Risk in Communities Study Investigators. Metab Clin Exp. 1996;45:699-706.
23. Memon RA, Feingold KR, Grunfeld C. Cytokines and intermediary metabolism. In: Remick DG, Friedland JS, eds. Cytokines in Health and Disease. 2nd ed. New York: Marcel Dekker; 1997, pp. 381-99.
24. Schmidt MI, Duncan BB, Sharrett AR, et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet. 1999;353:1649-52.
25. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: association with obesity, insulin resistance, and endothelial dysfunction. Arterioscler Thromb Vasc Biol. 1999;19:972-8.
26. Mansfield MW, Heywood DM, Grant PJ. Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM. Circulation. 1996;94:2171-6.
27. Duncan BB, Schmidt MI, Offenbacher S, Wu KK, Savage PJ, Heiss G. Factor VIII and other hemostasis variables are related to incident diabetes in adults - the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care. 1999;22:767-72.
28. Festa A, D'Agostino RB, Howard G, Mykkanen L, Tracy RP, Haffner SM. Inflammation and the insulin resistance syndrome in healthy subjects. The Insulin Resistance Atherosclerosis Study (IRAS). Diabetologia. 1999;42(Suppl. 1):A60 (abstr).
29. Pratley R, Wilson C, Bogardus C. Relation of white blood cell count to obesity and insulin resistance: effect of race and gender. Obes Res. 1995;3:563-71.
30. Tracy RP, Psaty BM, Macy E, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997; 17:2167-76.
31. Wilson PWF, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159:1104-9.
32. Everson SA, Goldberg DE, Helmrich SP, et al. Weight gain and the risk of developing the insulin resistance syndrome. Diabetes Care. 1998;21:1637-43.
33. ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1989;129:687-702.
34. National Heart Lung and Blood Institute. Atherosclerosis Risk in Communities (ARIC) Study Protocol, Manual 9: Hemostasis Determinations. University of North Carolina: School of Public Health; 1987.
35. Papp AC, Hatzakis H, Bracey A, Wu KK. ARIC hemostasis study, I. Development of blood collection and processing system suitable for multicenter hemostatic studies. Thromb Haemost. 1989;61:15-9.
36. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957;17:237-46.
37. Doumas BT, Watson WA, Biggs HG. Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chim Acta. 1971;31:87-96.
38. Chambless LE, McMahon RL, Wu KK, Folsom AR, Finch A, Shen Y-L. Short-term intraindividual variability in hemostasis factors, the ARIC Study. Ann Epidemiol. 1992;2:723-33.
39. Baecke JAH, Burema J, Frijters JER. A short questionnaire for the measurement of habitual physical activity in epidemiologic studies. Am J Clin Nutr. 198;36:936-42.
40. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20:1183-97.
41. Coakley EH, Rimm EB, Colditz G, Kawachi I, Willett W. Predictors of weight change in men: results from the Health Professionals Follow-up Study. Int J Obes Relat Metab Disord. 1998;22:89-96.
42. Liu S, Serdula MK, Williamson DF, Mokdad AH, Byers T. A prospective study of alcohol intake and change in body weight among US adults. Am J Epidemiol. 1994;140:912-20.
43. Dosquet C, Weill D, Wautier J-L. Cytokines and thrombosis. J Cardiovasc Pharmacol. 1995;25(Suppl 2):S13-S19.
44. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today. 1994;15:81-8.
45. Kushner I, Mackiewicz A. The acute phase response: an overview. In: Mackiewicz A, Kushner I, Baumann H, eds. Acute Phase Proteins: Molecular Biology, Biochemistry, and Clinical Applications. Boca Raton, FL: CRC Press; 1993, pp. 4-19.
46. Mathonnet F, Mazancourt PD, Denninger MH, Morot M, Benattar N, Giudicelli Y. Role of factor VIII on activated protein C resistance ratio in inflammatory diseases. Br J Haematol. 1996;95:423-5.
47. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J. 1998;12:57-65.
48. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature. 1997;389:610-4.
49. Chua SCJ, Chung WK, Wu-Peng XS, et al. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor. Science. 1996;271:994-6.
50. Spiegelman BM. PPAR-γ: adipogenic regulator and thiazolidinedione receptor. Diabetes. 1998;47:507-14.
51. Tracey KJ. Tumor necrosis factor. In: Remick DG, Friedland JS, eds. Cytokines in Health and Disease. 2nd ed. New York: Marcel Dekker, Inc.; 1997, pp. 223-40.
52. Fernandez-Real JM, Gutierrez C, Ricart W, et al. The TNF-α gene NcoI polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes. 1997;46:1468-72.
53. Haffner SM, Mykkanen LA, Gonzalez CC, Stern MP. Leptin concentrations do not predict weight gain: the Mexico City Diabetes Study. Int J Obes Relat Metab Disord. 1998; 22:695-9.
54. Hodge AM, de Courten MP, Dowse GK, et al. Do leptin levels predict weight gain? - A 5-year follow-up study in Mauritius. Mauritius Non-communicable Disease Study Group. Obes Res. 1998;6:319-25.
55. Ravussin E, Pratley RE, Mafei M, et al. Relatively low plasma leptin concentrations precede weight gain in Pima Indians. Nat Med. 1997;3:238-40.